FABP4 was significantly correlated with “immune response_lectin-induced complement pathway”, “immune response_classical complement pathway”, and “COVID-19-associated coagulopathy” in the development of CRC (Figure S5, Table S5). The gene discussed is FABP4; the disease is COVID-19.